[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100440051":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":24,"centralContacts":28,"locations":36,"responsibleParty":52,"collaborators":55,"id":59,"slug":60,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":64,"acronym":65,"eligibilityCriteria":66,"healthyVolunteers":61,"sex":67,"minAge":68,"maxAge":10,"enrollmentInfo":69,"targetDuration":10,"studyType":72,"phases":10,"briefSummary":73,"conditions":74,"keywords":76,"overallStatus":38,"whyStopped":10,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"Massachusetts General Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Use of advanced neurotechnologies to detect consciousness and predict recovery",null,"Treating clinicians, family members (caregivers) and patients recovering from a diagnosis of coma, vegetative state, or minimally conscious state minus (i.e. minimally conscious state without language function)",[13,14],"Other: Clinician Questionnaire","Other: Semi Structured Interviews",[16,20],{"type":6,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"Clinician Questionnaire","Surveys will serve to identify preferences, expectations and concerns among clinicians and researchers surrounding data-sharing of uncertain diagnostic data generated through investigative neurotechnologies which will then be systematically evaluated.",[9],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":10},"Semi Structured Interviews","Semi-structured interviews will further serve to identify preferences, expectations and concerns among patients, surrogates, clinicians and researchers surrounding data-sharing of uncertain diagnostic data generated through these investigative neurotechnologies which will then be systematically evaluated.",[9],[25],{"name":26,"affiliation":5,"role":27},"Michael Young, MD","PRINCIPAL_INVESTIGATOR",[29,33],{"name":26,"role":30,"phone":31,"phoneExt":10,"email":32},"CONTACT","617-724-6352","Michael.Young@MGH.HARVARD.EDU",{"name":34,"role":30,"phone":31,"phoneExt":10,"email":35},"Brian Edlow, MD","bedlow@mgh.harvard.edu",[37],{"facility":5,"status":38,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"RECRUITING","Boston","Massachusetts","02114","United States","US",{"type":45,"coordinates":46},"Point",[47,48],-71.05977,42.35843,{"lat":48,"lon":47},[51],{"name":26,"role":30,"phone":10,"phoneExt":10,"email":32},{"type":27,"investigatorFullName":53,"investigatorTitle":54,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Michael J. Young, M.D., M.Phil","Principal Investigator",[56],{"name":57,"class":58},"National Institute of Mental Health (NIMH)","NIH","100440051","an-ethical-approach-to-detecting-covert-consciousness-100440051",false,"NCT05010265","An Ethical Approach to Detecting Covert Consciousness","An Ethical Approach to Detecting Covert Consciousness: Data-Driven Neuroethics for Consciousness Detection (DECODE)","DECODE","Inclusion Criteria:\n\n* Patients with prior or ongoing participation as subject in a research study using neurotechnologies for diagnosis and prognosis of disorders of consciousness (DoC) at Mass General Brigham\n* Patients capable of understanding and answering questions in English\n* Patients cble to provide informed consent\n* Patients for whom MRI \u002F EEG are administered for clinical detection of consciousness and\u002For neuroprognostication\n* Family member or surrogate caregiver of patients who previously participated or are currently participating in a research study using neurotechnologies for diagnosis and prognosis of DoC at Mass General Brigham.\n* Family Members \u002F Surrogates capable of understanding and answering questions in English\n* Family Members \u002F Surrogates able to provide informed consent\n* Family member or surrogate caregiver of patients for whom MRI \u002F EEG are administered for clinical detection of consciousness and\u002For neuroprognostication\n* Research Investigators involved with research responsibilities in designing or testing neurotechnologies on patients with DoC.\n* Clinicians with clinical responsibilities caring for patients in behaviorally unresponsive state, defined as coma, vegetative state (VS), and low-level minimally conscious state (MCS).\n* Selected leaders and advisors (Community and Thought Leaders) from brain injury associations and advocacy organizations, and policy-makers involved in decision-making impacting patients with DoC.\n\nExclusion Criteria:\n\nNone","ALL","18 Years",{"count":70,"type":71},70,"ESTIMATED","OBSERVATIONAL","This study aims to develop an ethical approach to developing and deploying novel neurotechnologies to aid in the detection of consciousness and prediction of recovery after brain injury.",[75],"Disorder of Consciousness",[77],"Disorders of consciousness, Advanced neuroimaging","2025-09-05",{"date":80,"type":81},"2025-09-11","ACTUAL",{"date":83,"type":81},"2022-02-01",{"date":85,"type":71},"2027-07",{"name":5,"class":6},1]